Stocktoria

PDS Biotechnology Corp PDSB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-10-01 · LEI

PDS Biotechnology Corp statistics & valuation

Market cap$49.6M
P / B5.4×
Return on capital-150.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-43.50% -59.80% -54.70% -26.80% -92.80% -164.30% -197.90% -372.90% 2016201720182019202020212022202320242025
Shares outstanding
28.9M 30.9M 3.4M 5.3M 22.3M 28.4M 30.2M 33.1M 38.0M 54.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-35.00% -54.90% -2333.20% -48.30% -48.10% -25.20% -53.10% -72.30% -82.90% -113.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.89 -$0.66 -$1.43 -$1.39 -$1.03 -$0.74 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-113.1%-82.9%-72.3%-53.1%-25.2%-48.1%-48.3%-2333.2%-54.9%-35.0%
Return on equity-372.9%-197.9%-164.3%-92.8%-26.8%-54.7%-59.8%185.7%8344.1%-43.5%
Current ratio2.982.644.337.7917.809.285.180.066.9216.06

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.